MIKE18181
3 months ago
Accounting made the -10m loss look smaller.
Curveball acconting since you like baseball. Closing of BRL not yet, so streamling was Not the real reason. Why, easy one you would have seen a loss in revenue as assets were sold.
So - 25,000,000 per quater minus axtual revene.
^Remember 100m in revs gone, as the unloaded BRL business segment.. 10% buy back is needed as the Dead Dog is obese with too many shares..
MIKE18181
5 months ago
Department of justice (DOJ, SEC and more). We dont want an anti trust or monopoly or unfair business / competion that hurts consumers !!!
Ok, listen.. but you allow a CEO Phillip Frost to control the common stock, Mislead, Lie , Harm hardworkibg shareholders..
Look at the results since 2006.
Should have been fired for losses to all Opk shareholders. " to be held accoutable for lack of performance "...
MIKE18181
8 months ago
Yes, I wrote about Yvonne Briggs IR, and said as I asked a simple question, I started to probe other harder.
Result backed off, and told me to read the Q reports . I called you, because you the Investir relation support. I got more calls gotta go.
This will be sold and the time frame to me looks like 2 qtrs
homeboy
8 months ago
The reason we ask questions directly to management is there is an underlying tone that is not open with this company. I highlighted that with Adam Logal during the conference call mentioning the repurchase of shares. That was a deflection from what was really going on… Yvonne tries to come across as being open at the investor relations department. As a former business owner, I can assure you what you get from investor relations is scripted to what has been publicly released only. Behind the scenes is a different world. We (our team of investors) are betting on some type of buyout. Elias is in his 70s, Frost is near 90. Those are the main characters. Both cut from the same mold…grow the business, then sell it. Very common practice.
What Yvonne tells about the current outstanding shares is only part of the story. In a buyout, many of those reserved shares would also have to be honored. So, being conservative 1,000,000,000 shares at this point would be the buyout amount. For example: a buyout at 7 dollars would represent a 7 billion dollar purchase. Modex has value potential we think. As many here have said, the lab has been a nemesis and OPKO has not reacted fast enough. There was a reason the former owner was happy to sell Bio for 1.5 billion. We can see clearly now. But what remains a mystery is why OPKO continues to fund it at a deficit in the hundreds of millions? On another note…
We will be traveling for a while until mid June to China. Until then, hopefully OPKO will have some good fortune during the interim.
homeboy
8 months ago
I inquired about the specifics to increase the share count:
“The Board has unanimously adopted and declared advisable, and has recommended that the Company's stockholders approve, the Charter Amendment, which would amend the Certificate of Incorporation to increase the number of authorized shares of common stock from 1,000,000,000 to 1,250,000,000.
In addition to the 726,764,700 shares of common stock issued and outstanding (including treasury shares) as of the record date, the Board has reserved an aggregate of 418,733,078 additional shares for future issuance, consisting of the following: (a) 53,731,069 shares reserved for issuance upon the exercise of outstanding employee stock options; (b) 32,912,579 shares reserved for future issuance of awards under the 2016 Equity Incentive Plan; (c) 48,295 shares reserved for issuance upon conversion of the Company's outstanding 4.50% convertible senior notes due 2025 issued in February 2019; (d) 8,489 shares reserved for issuance upon conversion of the Company's outstanding 2033 convertible senior notes issued in January 2013; and (e) 332,032,646 shares reserved for issuance upon conversion of the Company's outstanding 3.75% Convertible Senior Notes due 2029 issued in January 2024.
As a result, the Company currently has no authorized but unissued shares of common stock (including treasury shares) that are unreserved and available for future issuance.”